Ginsenoside Rh2 inhibits thyroid cancer cell migration and proliferation via activation of miR-524-5p
Introduction Thyroid cancer is an important disease that threatens the health of humans. Ginsenoside Rh2 is known as an anticancer molecule; however, its function in thyroid cancer cells has not been reported. In the present study, we identified that Rh2 treatment of the thyroid cancer cell line K1...
Main Authors: | Shan Jiang, Jiqi Yan, Xingsheng Chen, Qingji Xie, Wei Lin, Ting Lin, Qinyu Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Termedia Publishing House
2020-02-01
|
Series: | Archives of Medical Science |
Subjects: | |
Online Access: | https://www.archivesofmedicalscience.com/Ginsenoside-Rh2-inhibits-thyroid-cancer-cell-migration-and-proliferation-via-activation,108932,0,2.html |
Similar Items
-
miR-524-5p reduces the progression of the BRAF inhibitor-resistant melanoma
by: Mai-Huong Thi Nguyen, et al.
Published: (2020-12-01) -
Glycosyltransformation of ginsenoside Rh2 into two novel ginsenosides using recombinant glycosyltransferase from Lactobacillus rhamnosus and its in vitro applications
by: Dan-Dan Wang, et al.
Published: (2021-01-01) -
Biotransformation of Ginsenoside Rf to Rh1 by Recombinant β-Glucosidase
by: Yi-Nan Zheng, et al.
Published: (2009-06-01) -
Anticancer activity of ginsenosides Rh2 on various cancer cells
by: Seun Eui Kim, et al.
Published: (2023-09-01) -
Ginsenoside Rh2 suppresses colon cancer growth by targeting the miR-150-3p/SRCIN1/Wnt axis
by: Li Shipeng, et al.
Published: (2023-03-01)